SENNA- sennosides tablet 
Akron Pharma Inc.

----------

Senna Tablets
Natural Vegitable Lexative

Drug Facts

Active ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

Do not use

Do not use

laxative products for longer than one week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative.

These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health care professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

agestarting dosagemaximum dosage

Adults and children

12 years of age and older

2 tablets

once a day

4 tablets

twice a day

Children 6 to under

12 years of age

1 tablet

once a day

2 tablets

twice a day

Children 2 to under

6 years of age

1/2 tablet

once a day

1 tablet

twice a day

Children under

2 years of age

ask a doctor

ask a doctor

Other information

Inactive ingredients

microcrystaline cellulose, dicalcium phosphate, sodium starch glycolate, croscarmellose sodium, hypromellose, povidone, collodial silicon dioxide, megnesium stearate. 

Questions or comments?

1-(877) 255-6999

Tamper Evident:

Do not use if imprinted inner safety seal is torn or missing.

This product is not manufactured or distributed by Purdue Products L.P.,

Owner of the registered trademark Senokot ®

Manufactured for:

Akron Pharma Inc

Fairfield, NJ 07004

www.akronpharma.com

100

100UD

1000

SENNA 
sennosides tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71399-1017
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSPOVIDONE (UNII: 2S7830E561)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)  
HYDROXYPROPYL METHYLCELLULOSE (UNII: 3NXW29V3WO)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POVIDONE (UNII: FZ989GH94E)  
SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
TALC (UNII: 7SEV7J4R1U)  
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize3mm
FlavorImprint Code 8;6;A
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71399-1017-1100 in 1 BOTTLE; Type 0: Not a Combination Product12/06/2024
2NDC:71399-1017-21000 in 1 BOTTLE; Type 0: Not a Combination Product12/06/2024
3NDC:71399-1017-3100 in 1 PACKAGE12/06/2024
31 in 1 PACKET; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00712/06/2024
Labeler - Akron Pharma Inc. (067878881)

Revised: 5/2025
Document Id: 35428dd1-59c5-58f3-e063-6394a90af628
Set id: 55ce3969-d7a6-49c4-8c13-d95690efc1a6
Version: 5
Effective Time: 20250516
 
Akron Pharma Inc.